Elbit Medical Technologies (XTAE:EMTC-M) ROCE % : -236.14% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Elbit Medical Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elbit Medical Technologies's annualized ROCE % for the quarter that ended in Dec. 2023 was -236.14%.

Elbit Medical Technologies ROCE % Historical Data

The historical data trend for Elbit Medical Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Medical Technologies ROCE % Chart

Elbit Medical Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-96.27

270.65

-23.71

-18.40

-110.43

Elbit Medical Technologies Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-63.01	-2.37	-37.42	-2.21	-236.14

Elbit Medical Technologies ROCE % Calculation

Elbit Medical Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-66.262	/	( ( (95.081 - 1.944)	+	(27.609 - 0.734) )	/ 2 )
	=	-66.262	/	( (93.137	+	26.875)	/ 2 )
	=	-66.262	/	60.006
	=	-110.43 %

Elbit Medical Technologies's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-130.574	/	( ( (84.572 - 0.856)	+	(27.609 - 0.734) )	/ 2 )
	=	-130.574	/	( ( 83.716	+	26.875 )	/ 2 )
	=	-130.574	/	55.2955
	=	-236.14 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Elbit Medical Technologies (XTAE:EMTC-M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elbit Medical Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Elbit Medical Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elbit Medical Technologies (XTAE:EMTC-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Medical Technologies Ltd (XTAE:EMTC-M) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimshon Street 3, Petah Tikva, ISR, 4900102

Website

https://www.elbitsystems.com

Elbit Medical Technologies Ltd is a holding company in the biomedical field. It has investments in two subsidiaries namely, InSightec & Gamida Cell. Through these divisions it develops & markets magnetic resonance imaging guided ultrasound equipment & develops stem cell therapeutics & future regenerative cell-based medicines.

Elbit Medical Technologies (XTAE:EMTC-M) Headlines

No Headlines